We're making nearly 300% gains on a rising pharmaceutical stock
Shortly after the opening bell, we will sell 10 shares of Eli Lilly at approximately $958 each. Following Monday's trade,…
Shortly after the opening bell, we will sell 10 shares of Eli Lilly at approximately $958 each. Following Monday's trade,…
Each weekday, CNBC's Investment Club with Jim Cramer publishes the final stretch, an action-packed afternoon update just in time for…
Jim Cramer's daily quick analysis of stocks making the news outside of the CNBC Investing Club portfolio. Lowe's: The home…
Teresa Heitsenrether is the company's director of data and analytics. Courtesy: Joe Vericker | PhotoBureau JPMorgan Chase has rolled out…
JPMorgan Chase Chief Executive Jamie Dimon said Wednesday he still believes the odds of a “soft landing” for the U.S.…
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…
Jeff Bezos at the Allen & Company Sun Valley Conference on July 10, 2024 in Sun Valley, Idaho. David Grogan…
Morgan Stanley Bitcoin on Friday told its army of financial advisors that it will soon allow them to offer bitcoin…
AI-generated responses are becoming more common, whether travelers know it or not. Westend61 | Getty Images An automated financial advisor…
GE Healthcare reported a mixed second quarter on Wednesday morning, and shares initially dipped sharply. Shares then reversed higher as…